Targeting interleukin-17 receptor B enhances gemcitabine sensitivity through downregulation of mucins in pancreatic cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting interleukin-17 receptor B enhances gemcitabine sensitivity through downregulation of mucins in pancreatic cancer
Authors
Keywords
-
Journal
Scientific Reports
Volume 10, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-10-20
DOI
10.1038/s41598-020-73659-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The role of pluripotency factors to drive stemness in gastrointestinal cancer
- (2016) Martin Müller et al. Stem Cell Research
- Targeting IL-17B–IL-17RB signaling with an anti–IL-17RB antibody blocks pancreatic cancer metastasis by silencing multiple chemokines
- (2015) Heng-Hsiung Wu et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Suppression of cancer relapse and metastasis by inhibiting cancer stemness
- (2015) Youzhi Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Key Roles of Hyaluronan and Its CD44 Receptor in the Stemness and Survival of Cancer Stem Cells
- (2015) Theerawut Chanmee et al. Frontiers in Oncology
- Pancreatic Adenocarcinoma
- (2015) David P. Ryan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gemcitabine Resistance is Associated with Epithelial-Mesenchymal Transition and Induction of HIF-1α in Pancreatic Cancer Cells
- (2014) Rui Wang et al. CURRENT CANCER DRUG TARGETS
- Combination of MUC1 and MUC4 expression predicts clinical outcome in patients with oral squamous cell carcinoma
- (2014) Yoshiaki Kamikawa et al. International Journal of Clinical Oncology
- Knockdown of Oct4 and Nanog expression inhibits the stemness of pancreatic cancer cells
- (2013) Yuhua Lu et al. CANCER LETTERS
- MUC4-induced nuclear translocation of β-catenin: A novel mechanism for growth, metastasis and angiogenesis in pancreatic cancer
- (2013) Xiaofei Zhi et al. CANCER LETTERS
- Autocrine/paracrine mechanism of interleukin-17B receptor promotes breast tumorigenesis through NF-κB-mediated antiapoptotic pathway
- (2013) C-K Huang et al. ONCOGENE
- MUC1 induces drug resistance in pancreatic cancer cells via upregulation of multidrug resistance genes
- (2013) S Nath et al. Oncogenesis
- The evolving concept of cancer and metastasis stem cells
- (2012) Irène Baccelli et al. JOURNAL OF CELL BIOLOGY
- The MUC4 mucin mediates gemcitabine resistance of human pancreatic cancer cells via the Concentrative Nucleoside Transporter family
- (2012) N Skrypek et al. ONCOGENE
- Pancreatic adenocarcinoma
- (2012) G. Bond-Smith et al. BMJ-British Medical Journal
- Pancreatic cancer
- (2011) Audrey Vincent et al. LANCET
- IL-25 Causes Apoptosis of IL-25R-Expressing Breast Cancer Cells Without Toxicity to Nonmalignant Cells
- (2011) S. Furuta et al. Science Translational Medicine
- MUC4 stabilizes HER2 expression and maintains the cancer stem cell population in ovarian cancer cells
- (2011) Moorthy P Ponnusamy et al. Journal of Ovarian Research
- The CD4+ T-cell transcriptome and serum IgE in asthma: IL17RB and the role of sex
- (2011) Gary M Hunninghake et al. BMC Pulmonary Medicine
- MUC4 down-regulation reverses chemoresistance of pancreatic cancer stem/progenitor cells and their progenies
- (2010) Murielle Mimeault et al. CANCER LETTERS
- Mucins and Pancreatic Cancer
- (2010) Nicolas Jonckheere et al. Cancers
- HMGA1 Is a Molecular Determinant of Chemoresistance to Gemcitabine in Pancreatic Adenocarcinoma
- (2008) S.-S. Liau et al. CLINICAL CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation